A detailed history of Successful Portfolios LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Successful Portfolios LLC holds 2,406 shares of GILD stock, worth $211,920. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,406
Holding current value
$211,920
% of portfolio
0.14%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$66.59 - $83.99 $160,215 - $202,079
2,406 New
2,406 $201,000
Q4 2023

Jan 18, 2024

SELL
$73.27 - $83.09 $1,099 - $1,246
-15 Reduced 0.55%
2,721 $220,000
Q3 2023

Oct 10, 2023

BUY
$73.94 - $80.67 $202,299 - $220,713
2,736 New
2,736 $205,000
Q1 2023

Apr 21, 2023

SELL
$77.31 - $88.08 $15,462 - $17,616
-200 Reduced 5.77%
3,266 $270,000
Q4 2022

Jan 27, 2023

BUY
$62.32 - $89.47 $216,001 - $310,103
3,466 New
3,466 $0
Q1 2022

Apr 21, 2022

SELL
$57.92 - $72.58 $196,522 - $246,263
-3,393 Closed
0 $0
Q4 2021

Jan 26, 2022

BUY
$64.88 - $73.64 $3,244 - $3,682
50 Added 1.5%
3,393 $246,000
Q3 2021

Oct 14, 2021

BUY
$67.69 - $73.03 $226,287 - $244,139
3,343 New
3,343 $234,000
Q3 2020

Oct 13, 2020

SELL
$62.1 - $78.08 $167,235 - $210,269
-2,693 Closed
0 $0
Q2 2020

Jul 13, 2020

SELL
$72.34 - $84.0 $13,310 - $15,456
-184 Reduced 6.4%
2,693 $207,000
Q1 2020

Apr 23, 2020

BUY
$62.63 - $80.22 $180,186 - $230,792
2,877 New
2,877 $215,000
Q4 2018

Jan 14, 2019

SELL
$60.54 - $79.0 $170,480 - $222,464
-2,816 Closed
0 $0
Q3 2018

Oct 15, 2018

SELL
$71.28 - $78.92 $8,767 - $9,707
-123 Reduced 4.19%
2,816 $217,000
Q2 2018

Jul 24, 2018

BUY
$64.88 - $75.68 $843 - $983
13 Added 0.44%
2,939 $208,000
Q1 2018

May 08, 2018

BUY
$72.84 - $88.8 $213,129 - $259,828
2,926 New
2,926 $221,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Successful Portfolios LLC Portfolio

Follow Successful Portfolios LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Successful Portfolios LLC, based on Form 13F filings with the SEC.

News

Stay updated on Successful Portfolios LLC with notifications on news.